SAS Drug Development Simplifies Data Management, Data Analysis and Regulatory Submissions
Source: SAS Institute
In its quest to discover new treatments for lethal, rapidly progressing forms of cancer, biopharmaceutical company NeoPharm has developed an impressive portfolio of cancer-fighting drugs. Currently, four of NeoPharm's drug compounds are in clinical trials - where physicians are studying these drug candidates' abilities to treat brain tumors and other forms of cancer without major side effects. At NeoPharm, SAS Drug Development provides the intelligence that the company needs to manage its research data effectively and to share that research with decision makers throughout the organization.
| Format: | HTML | Size: | 0.00 |
| Date: | Jan 2007 |
People who downloaded this item also downloaded
- Why Clinical Development Teams Should Care About Data Standards - Part I: An Introduction to the CDISC Operational Data Model (ODM)
- A "SAS Programmer's" Guide to SAS Enterprise Guide
